scholarly journals Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.

Thorax ◽  
1994 ◽  
Vol 49 (6) ◽  
pp. 545-548 ◽  
Author(s):  
J Tamaoki ◽  
A Chiyotani ◽  
E Tagaya ◽  
N Sakai ◽  
K Konno
Keyword(s):  
Chronic Bronchitis ◽  
Term Treatment ◽  
Diffuse Panbronchiolitis ◽  
Oxitropium Bromide ◽  
Airway Secretion ◽  
Long Term Treatment

Clinical Outcomes of Ambulatory Acute Exacerbations of Chronic Bronchitis with Older versus Newer Antimicrobials

2002 ◽  
Vol 36 (6) ◽  
pp. 975-980 ◽  
Author(s):  
Karl J Madaras-Kelly ◽  
Stephanie B Magdanz ◽  
Christopher K Johnson ◽  
Sandra G Jue
Keyword(s):  
Chronic Bronchitis ◽  
Term Treatment ◽  
Cure Rate ◽  
Term Outcome ◽  
Long Term Treatment ◽  
Acute Exacerbations ◽  
Short And Long Term ◽  
Traditional Therapies ◽  
Cure Rates

OBJECTIVE: To determine whether the cure rate was similar between traditional and newer antibiotics in the treatment of acute exacerbations of chronic bronchitis (AECB), to determine whether antibiotic selection during the first AECB of the season influences the frequency of subsequent AECB, and to identify variables associated with poor short- and long-term treatment outcome. METHODS: A retrospective analysis of subjects seen for management of their first seasonal AECB was conducted. Subjects were stratified into traditional therapies (n = 95) or newer therapies (n = 101) by antibiotic prescription. RESULTS: There was no difference in initial cure rates between older versus newer antibiotics (93% vs. 95%; p = 0.48). There was no difference in the number of subjects that remained AECB-free for 6 months after initial treatment with older versus newer antibiotic regimens (34% vs. 28%; p = 0.37). Oxygen initiation or increased dose (OR 10.9; 95% CI 1.4 to 84.2; p = 0.02) was the only variable independently associated with lack of AECB resolution. Nonsmoking status trended toward an association with remaining AECB-free at 180 days (OR 0.39; 95% CI 0.15 to 1.01; p = 0.053). CONCLUSIONS: The use of older versus newer antibiotics did not independently predict short-term outcome or future AECB.

Effect of Long-Term Treatment with Sobrerol on the Exacerbations of Chronic Bronchitis

Respiration ◽  
1986 ◽  
Vol 50 (3) ◽  
pp. 202-217 ◽  
Author(s):  
C.L. Castigiioni ◽  
C. Gramolini
Keyword(s):  
Chronic Bronchitis ◽  
Term Treatment ◽  
Long Term Treatment

Efficacy and Tolerability of Myrtol Standardized in Long-term Treatment of Chronic Bronchitis

2011 ◽  
Vol 49 (04) ◽  
pp. 351-358 ◽  
Author(s):  
Rolf Meister ◽  
Thomas Wittig ◽  
Norbert Beuscher ◽  
Christian de Mey ◽  
Keyword(s):  
Chronic Bronchitis ◽  
Term Treatment ◽  
Long Term Treatment

Hypnotherapy is effective in the long-term treatment of functional dyspepsia

2001 ◽  
Vol 120 (5) ◽  
pp. A115-A115 ◽  
Author(s):  
E CALVERT ◽  
L HOUGHTON ◽  
P COOPER ◽  
P WHORWELL
Keyword(s):  
Functional Dyspepsia ◽  
Term Treatment ◽  
Long Term Treatment

1608: Long-Term Treatment with High Doses of Sildenafil Does Not Up-Regulate the Levels of Phosphodiesterase 5 (Pde5) in the Rat Penis

2004 ◽  
Vol 171 (4S) ◽  
pp. 424-424 ◽  
Author(s):  
Monica G. Ferrini ◽  
Eliane G. Valente ◽  
Jacob Rajfer ◽  
Nestor F. Gonzalez-Cadavid
Keyword(s):  
Term Treatment ◽  
Long Term Treatment ◽  
High Doses ◽  
Phosphodiesterase 5
Sign in / Sign up

Export Citation Format

Share Document